skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Lipoprotein abnormalities in South Asians and its association with cardiovascular disease:Current state and future directions

World journal of cardiology, 2016-03, Vol.8 (3), p.247-257

The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. 2016 ;ISSN: 1949-8462 ;EISSN: 1949-8462 ;DOI: 10.4330/wjc.v8.i3.247 ;PMID: 27022456

Full text available

Citations Cited by
  • Title:
    Lipoprotein abnormalities in South Asians and its association with cardiovascular disease:Current state and future directions
  • Author: Bilen, Ozlem ; Kamal, Ayeesha ; Virani, Salim S
  • Subjects: Asians; Asian ; disease ; Dyslipidemia; South ; Indians; Cardiovascular ; Review
  • Is Part Of: World journal of cardiology, 2016-03, Vol.8 (3), p.247-257
  • Description: South Asians have a high prevalence of coronary heart disease(CHD) and suffer from early-onset CHD compared to other ethnic groups. Conventional risk factors may not fully explain this increased CHD risk in this population. Indeed, South Asians have a unique lipid profile which may predispose them to premature CHD. Dyslipidemia in this patient population seems to be an important contributor to the high incidence of coronary atherosclerosis. The dyslipidemia in South Asians is characterized by elevated levels of triglycerides, low levels of high-density lipoprotein(HDL) cholesterol, elevated lipoprotein(a) levels, and a higher atherogenic particle burden despite comparable low-density lipoprotein cholesterol levels compared with other ethnic subgroups. HDL particles also appear to be smaller, dysfunctional, and proatherogenic in South Asians. Despite the rapid expansion of the current literature with better understanding of the specific lipid abnormalities in this patient population, studies with adequate sample sizes are needed to assess the significance and contribution of a given lipid parameter on overall cardiovascular risk in this population. Specific management goals and treatment thresholds do not exist for South Asians because of paucity of data. Current treatment recommendations are mostly extrapolated from Western guidelines. Lastly, large, prospective studies with outcomes data are needed to assess cardiovascular benefit associated with various lipid-lowering therapies(including combination therapy) in this patient population.
  • Publisher: United States: Baishideng Publishing Group Inc
  • Language: English
  • Identifier: ISSN: 1949-8462
    EISSN: 1949-8462
    DOI: 10.4330/wjc.v8.i3.247
    PMID: 27022456
  • Source: GFMER Free Medical Journals
    PubMed Central

Searching Remote Databases, Please Wait